ZEO:NASDAQZeo Energy Corporation Analysis
Data as of 2026-07-31 - not real-time
$0.58
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Zeo Energy Corp. is trading just above its recent support level while the short‑term moving average remains below the mid‑term average, confirming a bearish price alignment. The relative strength index hovers around the neutral zone, suggesting limited upward momentum, yet the MACD line has crossed above its signal, offering a tentative bullish signal despite both lines staying in negative territory. Volume has been on a downtrend, and the 30‑day price volatility is exceptionally high, amplifying the risk of sharp moves. A beta well above the market and a historic drawdown of nearly eighty percent further underscore the stock’s sensitivity to market swings. Fundamentally, the company posts negative operating and profit margins, cash‑flow deficits, and a debt‑to‑equity ratio that signals leverage concerns, while its book value per share is negative, leading to a deeply negative price‑to‑book multiple.
The solar residential sector is inherently policy‑driven and capital‑intensive, adding medium to high regulatory and sector risk, though geographic exposure is limited to the United States, keeping currency risk low. Market sentiment is in an “extreme greed” phase, which may be inflating price expectations despite the distressed fundamentals. Consequently, the stock appears cheap on a price‑to‑sales basis but suffers from severe profitability and balance‑sheet weaknesses, making the overall risk profile high and the upside potential constrained without a clear turnaround.
The solar residential sector is inherently policy‑driven and capital‑intensive, adding medium to high regulatory and sector risk, though geographic exposure is limited to the United States, keeping currency risk low. Market sentiment is in an “extreme greed” phase, which may be inflating price expectations despite the distressed fundamentals. Consequently, the stock appears cheap on a price‑to‑sales basis but suffers from severe profitability and balance‑sheet weaknesses, making the overall risk profile high and the upside potential constrained without a clear turnaround.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price near technical support with bearish SMA alignment
- decreasing volume and extreme volatility
- negative margins and cash‑flow deficits
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential upside from MACD bullish crossover
- high beta may amplify market rebounds
- sector growth prospects if policy support improves
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- valuation appears cheap relative to sales
- ongoing structural challenges in profitability
- need for balance‑sheet restructuring to reduce leverage
Key Metrics & Analysis
Financial Health
Revenue Growth50.10%
Profit Margin-15.13%
ROE-29.34%
ROA-13.17%
Debt/Equity2.76
P/B Ratio-10.5
Op. Cash Flow$-7280825
Free Cash Flow$-8946159
Industry P/E32.9
Technical Analysis
TrendBearish
RSI47.0
Support$0.50
Resistance$0.70
MA 20$0.57
MA 50$0.69
MA 200$0.99
MACDBullish
VolumeDecreasing
Fear & Greed Index91.59
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.90
Volatility67.17%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.